 | • レポートコード：MRC2Q12-16780 • 出版社/出版日：QYResearch / 2022年12月 • レポート形態：英文、PDF、114ページ • 納品方法：Eメール（納期：3営業日） • 産業分類：医療 |
| Single User | ￥735,000 (USD4,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,470,000 (USD9,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 新型コロナウイルス感染症とロシア・ウクライナ戦争の影響により、ヒトゲノムシーケンシングのグローバル市場は 2022にxxxドルと推定され、2028年までにxxxドルの規模に達し、2022年から2028年の予測期間中にxxx%のCAGRで成長すると予測されています。 ヒトゲノムシーケンシングのアメリカ市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 ヒトゲノムシーケンシングの中国市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 ヒトゲノムシーケンシングのヨーロッパ市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 生産面において、本レポートは2017年から2022年までのヒトゲノムシーケンシングの生産、成長率、メーカー別市場シェア、地域別市場シェア、および2028年までの予測を調査しています。販売面において、本レポートは2017年から2022年までの地域別、企業別、タイプ別、アプリケーション別のヒトゲノムシーケンシングの売上および2028年までの予測に焦点を当てています。 ヒトゲノムシーケンシングのグローバル主要企業には、10x Genomics、23andME、Abbott、AccuraGen、Adaptive Biotechnologies、Admera Health、Agena Bioscience、Agilent Technologies、Akonni Biosystems、Ancestry、AnchorDx、Arc Bio、ArcherDx、ARUP Laboratories、Asuragen、Baylor Genetics、Beckman Coulter、Becton, Dickinson and Company、BGI Genomicsなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。 ヒトゲノムシーケンシング市場は、タイプとアプリケーションによって区分されます。世界のヒトゲノムシーケンシング市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別およびアプリケーション別の販売量、売上、予測に焦点を当てています。 【タイプ別セグメント】 エマルジョンポリメラーゼ連鎖反応、架橋増幅、単一分子 【アプリケーション別セグメント】 病院＆診療所、独立臨床検査室 【掲載地域】 北米：アメリカ、カナダ ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア 中南米：メキシコ、ブラジル、アルゼンチン 中東・アフリカ：トルコ、サウジアラビア、UAE 【目次（一部）】 ・調査の範囲 - ヒトゲノムシーケンシング製品概要 - タイプ別市場（エマルジョンポリメラーゼ連鎖反応、架橋増幅、単一分子） - アプリケーション別市場（病院＆診療所、独立臨床検査室） - 調査の目的 ・エグゼクティブサマリー - 世界のヒトゲノムシーケンシング販売量予測2017-2028 - 世界のヒトゲノムシーケンシング売上予測2017-2028 - ヒトゲノムシーケンシングの地域別販売量 - ヒトゲノムシーケンシングの地域別売上 - 北米市場 - ヨーロッパ市場 - アジア太平洋市場 - 中南米市場 - 中東・アフリカ市場 ・メーカーの競争状況 - 主要メーカー別ヒトゲノムシーケンシング販売量 - 主要メーカー別ヒトゲノムシーケンシング売上 - 主要メーカー別ヒトゲノムシーケンシング価格 - 競争状況の分析 - 企業M&A動向 ・タイプ別市場規模（エマルジョンポリメラーゼ連鎖反応、架橋増幅、単一分子） - ヒトゲノムシーケンシングのタイプ別販売量 - ヒトゲノムシーケンシングのタイプ別売上 - ヒトゲノムシーケンシングのタイプ別価格 ・アプリケーション別市場規模（病院＆診療所、独立臨床検査室） - ヒトゲノムシーケンシングのアプリケーション別販売量 - ヒトゲノムシーケンシングのアプリケーション別売上 - ヒトゲノムシーケンシングのアプリケーション別価格 ・北米市場 - 北米のヒトゲノムシーケンシング市場規模（タイプ別、アプリケーション別） - 主要国別のヒトゲノムシーケンシング市場規模（アメリカ、カナダ） ・ヨーロッパ市場 - ヨーロッパのヒトゲノムシーケンシング市場規模（タイプ別、アプリケーション別） - 主要国別のヒトゲノムシーケンシング市場規模（ドイツ、フランス、イギリス、イタリア、ロシア） ・アジア太平洋市場 - アジア太平洋のヒトゲノムシーケンシング市場規模（タイプ別、アプリケーション別） - 主要国別のヒトゲノムシーケンシング市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア） ・中南米市場 - 中南米のヒトゲノムシーケンシング市場規模（タイプ別、アプリケーション別） - 主要国別のヒトゲノムシーケンシング市場規模（メキシコ、ブラジル、アルゼンチン） ・中東・アフリカ市場 - 中東・アフリカのヒトゲノムシーケンシング市場規模（タイプ別、アプリケーション別） - 主要国別のヒトゲノムシーケンシング市場規模（トルコ、サウジアラビア） ・企業情報 10x Genomics、23andME、Abbott、AccuraGen、Adaptive Biotechnologies、Admera Health、Agena Bioscience、Agilent Technologies、Akonni Biosystems、Ancestry、AnchorDx、Arc Bio、ArcherDx、ARUP Laboratories、Asuragen、Baylor Genetics、Beckman Coulter、Becton, Dickinson and Company、BGI Genomics ・産業チェーン及び販売チャネル分析 - ヒトゲノムシーケンシングの産業チェーン分析 - ヒトゲノムシーケンシングの原材料 - ヒトゲノムシーケンシングの生産プロセス - ヒトゲノムシーケンシングの販売及びマーケティング - ヒトゲノムシーケンシングの主要顧客 ・マーケットドライバー、機会、課題、リスク要因分析 - ヒトゲノムシーケンシングの産業動向 - ヒトゲノムシーケンシングのマーケットドライバー - ヒトゲノムシーケンシングの課題 - ヒトゲノムシーケンシングの阻害要因 ・主な調査結果 |
Report Overview
Due to the COVID-19 pandemic and Russia-Ukraine War Influence, the global market for Human Genome Sequencing estimated at US$ million in the year 2022, is projected to reach a revised size of US$ million by 2028, growing at a CAGR of % during the forecast period 2022-2028.
The USA market for Human Genome Sequencing is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The China market for Human Genome Sequencing is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The Europe market for Human Genome Sequencing is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The global key companies of Human Genome Sequencing include 10x Genomics, 23andME, Abbott, AccuraGen, Adaptive Biotechnologies, Admera Health, Agena Bioscience, Agilent Technologies and Akonni Biosystems, etc. In 2021, the global top five players had a share approximately % in terms of revenue.
Report Scope
This latest report researches the industry structure, revenue and gross margin. Major players’ headquarters, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the Human Genome Sequencing companies, distributors, end users, industry associations, governments’ industry bureaus, industry publications, industry experts, third party database, and our in-house databases.
This report also includes a discussion of the major players across each regional Human Genome Sequencing market. Further, it explains the major drivers and regional dynamics of the global Human Genome Sequencing market and current trends within the industry.
Key Companies Covered
In this section of the report, the researchers have done a comprehensive analysis of the prominent players operating and the strategies they are focusing on to combat the intense competition. Company profiles and market share analysis of the prominent players are also provided in this section. Additionally, the specialists have done an all-encompassing analysis of each player. They have also provided reliable revenue, market share and rank data of the companies for the period 2017-2022. With the assistance of this report, key players, stakeholders, and other participants will be able to stay abreast of the recent and upcoming developments in the business, further enabling them to make efficient choices. Mentioned below are the prime players taken into account in this research report:
10x Genomics
23andME
Abbott
AccuraGen
Adaptive Biotechnologies
Admera Health
Agena Bioscience
Agilent Technologies
Akonni Biosystems
Ancestry
AnchorDx
Arc Bio
ArcherDx
ARUP Laboratories
Asuragen
Baylor Genetics
Beckman Coulter
Becton, Dickinson and Company
BGI Genomics
Market Segments
This report has explored the key segments: by Type and by Application. The lucrativeness and growth potential have been looked into by the industry experts in this report. This report also provides revenue forecast data by type and by application segments based on value for the period 2017-2028.
Human Genome Sequencing Segment by Type
Emulsion Polymerase Chain Reaction
Bridge Amplification
Single Molecule
Human Genome Sequencing Segment by Application
Hospitals and Clinics
Independent Clinical Laboratories
Key Regions & Countries
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the value data of each region and country for the period 2017-2028.
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Human Genome Sequencing market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Report Includes:
This report presents an overview of global market for Human Genome Sequencing market size. Analyses of the global market trends, with historic market revenue data for 2017 – 2021, estimates for 2022, and projections of CAGR through 2028.
This report researches the key producers of Human Genome Sequencing, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Human Genome Sequencing, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Human Genome Sequencing revenue, market share and industry ranking of main companies, data from 2017 to 2022. Identification of the major stakeholders in the global Human Genome Sequencing market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, revenue, and growth rate, from 2017 to 2028. Evaluation and forecast the market size for Human Genome Sequencing revenue, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including 10x Genomics, 23andME, Abbott, AccuraGen, Adaptive Biotechnologies, Admera Health, Agena Bioscience, Agilent Technologies and Akonni Biosystems, etc.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Human Genome Sequencing in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Human Genome Sequencing companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments according to product types, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments according to application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America by type, by application and by country, revenue for each segment.
Chapter 7: Europe by type, by application and by country, revenue for each segment.
Chapter 8: Asia Pacific by type, by application and by country/region, revenue for each segment.
Chapter 9: Latin America by type, by application and by country, revenue for each segment.
Chapter 10: Middle East and Africa by type, by application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Human Genome Sequencing revenue, gross margin, and recent development, etc.
Chapter 12: Analyst’s Viewpoints/Conclusions
1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Human Genome Sequencing Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Emulsion Polymerase Chain Reaction
1.2.3 Bridge Amplification
1.2.4 Single Molecule
1.3 Market by Application
1.3.1 Global Human Genome Sequencing Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospitals and Clinics
1.3.3 Independent Clinical Laboratories
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Human Genome Sequencing Market Perspective (2017-2028)
2.2 Human Genome Sequencing Growth Trends by Region
2.2.1 Human Genome Sequencing Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Human Genome Sequencing Historic Market Size by Region (2017-2022)
2.2.3 Human Genome Sequencing Forecasted Market Size by Region (2023-2028)
2.3 Human Genome Sequencing Market Dynamics
2.3.1 Human Genome Sequencing Industry Trends
2.3.2 Human Genome Sequencing Market Drivers
2.3.3 Human Genome Sequencing Market Challenges
2.3.4 Human Genome Sequencing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Human Genome Sequencing Players by Revenue
3.1.1 Global Top Human Genome Sequencing Players by Revenue (2017-2022)
3.1.2 Global Human Genome Sequencing Revenue Market Share by Players (2017-2022)
3.2 Global Human Genome Sequencing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Human Genome Sequencing Revenue
3.4 Global Human Genome Sequencing Market Concentration Ratio
3.4.1 Global Human Genome Sequencing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Human Genome Sequencing Revenue in 2021
3.5 Human Genome Sequencing Key Players Head office and Area Served
3.6 Key Players Human Genome Sequencing Product Solution and Service
3.7 Date of Enter into Human Genome Sequencing Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Human Genome Sequencing Breakdown Data by Type
4.1 Global Human Genome Sequencing Historic Market Size by Type (2017-2022)
4.2 Global Human Genome Sequencing Forecasted Market Size by Type (2023-2028)
5 Human Genome Sequencing Breakdown Data by Application
5.1 Global Human Genome Sequencing Historic Market Size by Application (2017-2022)
5.2 Global Human Genome Sequencing Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Human Genome Sequencing Market Size (2017-2028)
6.2 North America Human Genome Sequencing Market Size by Type
6.2.1 North America Human Genome Sequencing Market Size by Type (2017-2022)
6.2.2 North America Human Genome Sequencing Market Size by Type (2023-2028)
6.2.3 North America Human Genome Sequencing Market Share by Type (2017-2028)
6.3 North America Human Genome Sequencing Market Size by Application
6.3.1 North America Human Genome Sequencing Market Size by Application (2017-2022)
6.3.2 North America Human Genome Sequencing Market Size by Application (2023-2028)
6.3.3 North America Human Genome Sequencing Market Share by Application (2017-2028)
6.4 North America Human Genome Sequencing Market Size by Country
6.4.1 North America Human Genome Sequencing Market Size by Country (2017-2022)
6.4.2 North America Human Genome Sequencing Market Size by Country (2023-2028)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Human Genome Sequencing Market Size (2017-2028)
7.2 Europe Human Genome Sequencing Market Size by Type
7.2.1 Europe Human Genome Sequencing Market Size by Type (2017-2022)
7.2.2 Europe Human Genome Sequencing Market Size by Type (2023-2028)
7.2.3 Europe Human Genome Sequencing Market Share by Type (2017-2028)
7.3 Europe Human Genome Sequencing Market Size by Application
7.3.1 Europe Human Genome Sequencing Market Size by Application (2017-2022)
7.3.2 Europe Human Genome Sequencing Market Size by Application (2023-2028)
7.3.3 Europe Human Genome Sequencing Market Share by Application (2017-2028)
7.4 Europe Human Genome Sequencing Market Size by Country
7.4.1 Europe Human Genome Sequencing Market Size by Country (2017-2022)
7.4.2 Europe Human Genome Sequencing Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Human Genome Sequencing Market Size (2017-2028)
8.2 Asia-Pacific Human Genome Sequencing Market Size by Type
8.2.1 Asia-Pacific Human Genome Sequencing Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Human Genome Sequencing Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Human Genome Sequencing Market Share by Type (2017-2028)
8.3 Asia-Pacific Human Genome Sequencing Market Size by Application
8.3.1 Asia-Pacific Human Genome Sequencing Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Human Genome Sequencing Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Human Genome Sequencing Market Share by Application (2017-2028)
8.4 Asia-Pacific Human Genome Sequencing Market Size by Region
8.4.1 Asia-Pacific Human Genome Sequencing Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Human Genome Sequencing Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Human Genome Sequencing Market Size (2017-2028)
9.2 Latin America Human Genome Sequencing Market Size by Type
9.2.1 Latin America Human Genome Sequencing Market Size by Type (2017-2022)
9.2.2 Latin America Human Genome Sequencing Market Size by Type (2023-2028)
9.2.3 Latin America Human Genome Sequencing Market Share by Type (2017-2028)
9.3 Latin America Human Genome Sequencing Market Size by Application
9.3.1 Latin America Human Genome Sequencing Market Size by Application (2017-2022)
9.3.2 Latin America Human Genome Sequencing Market Size by Application (2023-2028)
9.3.3 Latin America Human Genome Sequencing Market Share by Application (2017-2028)
9.4 Latin America Human Genome Sequencing Market Size by Country
9.4.1 Latin America Human Genome Sequencing Market Size by Country (2017-2022)
9.4.2 Latin America Human Genome Sequencing Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Human Genome Sequencing Market Size (2017-2028)
10.2 Middle East & Africa Human Genome Sequencing Market Size by Type
10.2.1 Middle East & Africa Human Genome Sequencing Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Human Genome Sequencing Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Human Genome Sequencing Market Share by Type (2017-2028)
10.3 Middle East & Africa Human Genome Sequencing Market Size by Application
10.3.1 Middle East & Africa Human Genome Sequencing Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Human Genome Sequencing Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Human Genome Sequencing Market Share by Application (2017-2028)
10.4 Middle East & Africa Human Genome Sequencing Market Size by Country
10.4.1 Middle East & Africa Human Genome Sequencing Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Human Genome Sequencing Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 10x Genomics
11.1.1 10x Genomics Company Details
11.1.2 10x Genomics Business Overview
11.1.3 10x Genomics Human Genome Sequencing Introduction
11.1.4 10x Genomics Revenue in Human Genome Sequencing Business (2017-2022)
11.1.5 10x Genomics Recent Developments
11.2 23andME
11.2.1 23andME Company Details
11.2.2 23andME Business Overview
11.2.3 23andME Human Genome Sequencing Introduction
11.2.4 23andME Revenue in Human Genome Sequencing Business (2017-2022)
11.2.5 23andME Recent Developments
11.3 Abbott
11.3.1 Abbott Company Details
11.3.2 Abbott Business Overview
11.3.3 Abbott Human Genome Sequencing Introduction
11.3.4 Abbott Revenue in Human Genome Sequencing Business (2017-2022)
11.3.5 Abbott Recent Developments
11.4 AccuraGen
11.4.1 AccuraGen Company Details
11.4.2 AccuraGen Business Overview
11.4.3 AccuraGen Human Genome Sequencing Introduction
11.4.4 AccuraGen Revenue in Human Genome Sequencing Business (2017-2022)
11.4.5 AccuraGen Recent Developments
11.5 Adaptive Biotechnologies
11.5.1 Adaptive Biotechnologies Company Details
11.5.2 Adaptive Biotechnologies Business Overview
11.5.3 Adaptive Biotechnologies Human Genome Sequencing Introduction
11.5.4 Adaptive Biotechnologies Revenue in Human Genome Sequencing Business (2017-2022)
11.5.5 Adaptive Biotechnologies Recent Developments
11.6 Admera Health
11.6.1 Admera Health Company Details
11.6.2 Admera Health Business Overview
11.6.3 Admera Health Human Genome Sequencing Introduction
11.6.4 Admera Health Revenue in Human Genome Sequencing Business (2017-2022)
11.6.5 Admera Health Recent Developments
11.7 Agena Bioscience
11.7.1 Agena Bioscience Company Details
11.7.2 Agena Bioscience Business Overview
11.7.3 Agena Bioscience Human Genome Sequencing Introduction
11.7.4 Agena Bioscience Revenue in Human Genome Sequencing Business (2017-2022)
11.7.5 Agena Bioscience Recent Developments
11.8 Agilent Technologies
11.8.1 Agilent Technologies Company Details
11.8.2 Agilent Technologies Business Overview
11.8.3 Agilent Technologies Human Genome Sequencing Introduction
11.8.4 Agilent Technologies Revenue in Human Genome Sequencing Business (2017-2022)
11.8.5 Agilent Technologies Recent Developments
11.9 Akonni Biosystems
11.9.1 Akonni Biosystems Company Details
11.9.2 Akonni Biosystems Business Overview
11.9.3 Akonni Biosystems Human Genome Sequencing Introduction
11.9.4 Akonni Biosystems Revenue in Human Genome Sequencing Business (2017-2022)
11.9.5 Akonni Biosystems Recent Developments
11.10 Ancestry
11.10.1 Ancestry Company Details
11.10.2 Ancestry Business Overview
11.10.3 Ancestry Human Genome Sequencing Introduction
11.10.4 Ancestry Revenue in Human Genome Sequencing Business (2017-2022)
11.10.5 Ancestry Recent Developments
11.11 AnchorDx
11.11.1 AnchorDx Company Details
11.11.2 AnchorDx Business Overview
11.11.3 AnchorDx Human Genome Sequencing Introduction
11.11.4 AnchorDx Revenue in Human Genome Sequencing Business (2017-2022)
11.11.5 AnchorDx Recent Developments
11.12 Arc Bio
11.12.1 Arc Bio Company Details
11.12.2 Arc Bio Business Overview
11.12.3 Arc Bio Human Genome Sequencing Introduction
11.12.4 Arc Bio Revenue in Human Genome Sequencing Business (2017-2022)
11.12.5 Arc Bio Recent Developments
11.13 ArcherDx
11.13.1 ArcherDx Company Details
11.13.2 ArcherDx Business Overview
11.13.3 ArcherDx Human Genome Sequencing Introduction
11.13.4 ArcherDx Revenue in Human Genome Sequencing Business (2017-2022)
11.13.5 ArcherDx Recent Developments
11.14 ARUP Laboratories
11.14.1 ARUP Laboratories Company Details
11.14.2 ARUP Laboratories Business Overview
11.14.3 ARUP Laboratories Human Genome Sequencing Introduction
11.14.4 ARUP Laboratories Revenue in Human Genome Sequencing Business (2017-2022)
11.14.5 ARUP Laboratories Recent Developments
11.15 Asuragen
11.15.1 Asuragen Company Details
11.15.2 Asuragen Business Overview
11.15.3 Asuragen Human Genome Sequencing Introduction
11.15.4 Asuragen Revenue in Human Genome Sequencing Business (2017-2022)
11.15.5 Asuragen Recent Developments
11.16 Baylor Genetics
11.16.1 Baylor Genetics Company Details
11.16.2 Baylor Genetics Business Overview
11.16.3 Baylor Genetics Human Genome Sequencing Introduction
11.16.4 Baylor Genetics Revenue in Human Genome Sequencing Business (2017-2022)
11.16.5 Baylor Genetics Recent Developments
11.17 Beckman Coulter
11.17.1 Beckman Coulter Company Details
11.17.2 Beckman Coulter Business Overview
11.17.3 Beckman Coulter Human Genome Sequencing Introduction
11.17.4 Beckman Coulter Revenue in Human Genome Sequencing Business (2017-2022)
11.17.5 Beckman Coulter Recent Developments
11.18 Becton, Dickinson and Company
11.18.1 Becton, Dickinson and Company Company Details
11.18.2 Becton, Dickinson and Company Business Overview
11.18.3 Becton, Dickinson and Company Human Genome Sequencing Introduction
11.18.4 Becton, Dickinson and Company Revenue in Human Genome Sequencing Business (2017-2022)
11.18.5 Becton, Dickinson and Company Recent Developments
11.19 BGI Genomics
11.19.1 BGI Genomics Company Details
11.19.2 BGI Genomics Business Overview
11.19.3 BGI Genomics Human Genome Sequencing Introduction
11.19.4 BGI Genomics Revenue in Human Genome Sequencing Business (2017-2022)
11.19.5 BGI Genomics Recent Developments
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer